NovaXS Biotech Overview
- Year Founded
-
2020
- Status
-
Out of Business
- Employees
-
4
- Latest Deal Type
-
Out of Business
NovaXS Biotech General Information
Description
Developer of a needle-free injector designed to deliver a generation of proactive, accessible, and personalized medicines for age-related diseases. The company's technology consists of an artificial intelligence-driven health span diagnostic system, a needleless medication delivery medical device, and a preventive healthcare center to treat age-related diseases, enabling doctors to overturn aging by preventing chronic diseases and immune system disorders.
Contact Information
Website
www.novaxs.coCorporate Office
- 965 West Chicago Avenue
- Chicago, IL 60642
- United States
Corporate Office
- 965 West Chicago Avenue
- Chicago, IL 60642
- United States
NovaXS Biotech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Out of Business | 05-Jun-2025 | Completed | Out of Business | |||
| 10. Secondary Transaction - Private | 25-Jan-2024 | Completed | Generating Revenue | |||
| 9. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 8. Early Stage VC | 01-Mar-2023 | Completed | Generating Revenue | |||
| 7. Accelerator/Incubator | 28-Feb-2023 | Completed | Generating Revenue | |||
| 6. Equity Crowdfunding | 04-Feb-2023 | Completed | Startup | |||
| 5. Accelerator/Incubator | 01-Jan-2023 | Completed | Startup | |||
| 4. Seed Round | 31-Mar-2022 | Completed | Startup | |||
| 3. Accelerator/Incubator | 01-Oct-2021 | Completed | Startup | |||
| 2. Accelerator/Incubator | 11-Jul-2021 | Completed | Startup |
NovaXS Biotech Comparisons
Industry
Financing
Details
NovaXS Biotech Competitors (1)
One of NovaXS Biotech’s competitors is NanoPass Technologies, a Venture Capital-Backed company based in Nes Ziona, Israel.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| NanoPass Technologies | Venture Capital-Backed | Nes Ziona, Israel |
NovaXS Biotech Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
NovaXS Biotech Patents
NovaXS Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240033431-A1 | Needle-free injection system | Pending | 30-Jul-2022 | ||
| US-20240033435-A1 | Needle-free injection system | Pending | 30-Jul-2022 | ||
| US-20240033436-A1 | Needle-free injection system | Pending | 30-Jul-2022 | ||
| WO-2024030811-A2 | Needle-free injection system | Inactive | 30-Jul-2022 | ||
| WO-2024030811-A3 | Needle-free injection system | Inactive | 30-Jul-2022 | A61M5/30 |
NovaXS Biotech Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
NovaXS Biotech FAQs
-
When was NovaXS Biotech founded?
NovaXS Biotech was founded in 2020.
-
Where is NovaXS Biotech headquartered?
NovaXS Biotech is headquartered in Chicago, IL.
-
What is the size of NovaXS Biotech?
NovaXS Biotech has 4 total employees.
-
What industry is NovaXS Biotech in?
NovaXS Biotech’s primary industry is Other Devices and Supplies.
-
Is NovaXS Biotech a private or public company?
NovaXS Biotech is a Private company.
-
What is NovaXS Biotech’s current revenue?
The current revenue for NovaXS Biotech is .
-
How much funding has NovaXS Biotech raised over time?
NovaXS Biotech has raised $1.53M.
-
Who are NovaXS Biotech’s competitors?
NanoPass Technologies is a competitor of NovaXS Biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
